pharma · Infertility in women undergoing assisted reproductive technologies (ART) · Intermediate risk, non-muscle invasive bladder cancer
Ferring Pharmaceuticals
Ferring Pharmaceuticals is a pharma organization headquartered in Mumbai, IN. Primary therapeutic focus areas include Infertility in women undergoing assisted reproductive technologies (ART), Intermediate risk, non-muscl
-, St-Prex, 1162, CH, Mumbai HQ
1950 Founded
6,228 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- -, St-Prex, 1162, CH, Mumbai
- Founded
- 1950
- Employees
- 6,228
- Programs
- 13
- Drugs
- 23
- Patents
- 0
ADSTILADRIN
Phase 3 · small molecule · Intermediate risk, non-muscle invasive bladder cancer
ADSTILADRIN for Intermediate risk, non-muscle invasive bladder cancer is a Phase 3 program (small_molecule) at Ferring Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code 000423
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Ferring Pharmaceuticals
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Intermediate risk, non-muscle invasive bladder cancer
- Status
- active
- Trials
- 1